Subscribe to one of our feedsfont size
PrintEditor's Picks
Back « ... 11 12 13 14 15 16 17 18 19 20 » Next
- Drug-resistant bacteria found to trick immune system
Reuters - Gene therapy unlikely cause in death
The Seattle Times - Merck Agrees to Pay $4.85 Billion for Vioxx Claims
The New York Times - Bid for Stem Cell Financing Was Late and Lukewarm, Organizers Concede
The New York Times - FDA Beefs Up Anemia Drug Warning Labels
The Street - Brain-boosting drugs spark ethical debate
Reuters - The Forgotten Code Cracker
Scientific American - China to take new steps to clean up drug industry
Reuters - Biocon readies for US, Europe off patent mart
Business Standard - In Tests, AIDS Vaccine Seemed to Increase Risk
The New York Times - Exercise on the Brain
The New York Times - Thinly spread funds make training hard
San Diego Union Tribune - A Model for Health Care That Pays for Quality
The New York Times - Causes of Death Are Linked to a Person's Weight
The New York Times - Stem cell vote flop
The Jersey Journal - Shell expands biofuels research deal with Codexis
The San Francisco Business Times - Vatican conference to study origin, development of embryo
Associated Press - Blood Pressure Vaccine Shows Promise
HealthDay News - Flying and Blood Clots: A Deadly Risk
The New York Times - Gene explains why breast-feeding makes kids smarter
Reuters - Whistle-blower Nissen's advice: Push past drug's failure
USA Today - What have we got for biotech billions?
The Age - Novacea ends late-stage trial of prostate cancer drug
Reuters - Bayer withdraws Trasylol anti-bleeding drug
Globe and Mail - Missteps on Both Sides Led to Health Bill Veto
The New York Times - Despite Setback, Hunt for Cholesterol Drug Not Over
The New York Times - Without enough sleep, children gain weight: study
Reuters - Newt protein may offer clues for human regeneration
Reuters - F.D.A. Is Unable to Ensure Drugs Are Safe, Panel Is Told
The New York Times - Expecting Presidential Veto, Senate Passes Child Health Measure
The New York Times - Little room for scientists in pharma's new generation
Financial Times - Dozens join racial discrimination suit against Eli Lilly
Indianapolis Star - Next step in stem cells: Human tests
CNNMoney - 47 million Americans lack health insurance: report
Reuters - Orthopedic firms reveal payments in settlement
Star Tribune - Firm: US Drug Sales Will Fall 17 Percent
Associated Press - Novartis' cancer drug, Tasigna approved in US
Pharmabiz - Jury nullifies patents held by Natick firm
Bloomberg - A powerful way of studying biology looks set for take-off
The Economist - Chemicals Flow Unchecked From China to Drug Market
The New York Times - Baseball's Drug Testing Lacks Element of Surprise
The New York Times - Non-English Speakers Charge Bias in Prescription Labeling
The New York Times - Small rival takes deep breath
The Los Angeles Times - Massachusetts Governor: State is losing edge in biotech
The Boston Globe - Participants Left Uninformed in Some Halted Medical Trials
The New York Times - New wave of job cuts hits health care
Reuters - 774 Arrests in China Over Safety
The New York Times - A stem cell pioneer applauds state's efforts as 'substantive'
The Star Ledger - Singapore's output down
In-Pharma Technologist - Pfizer says German court revokes Lipitor patent
Reuters - Health Sector Puts Its Money on Democrats
The New York Times - Novartis Plans $700 Million Singapore Biotech Plant
Bloomberg - Should we all be testing our DNA?
BBC - A Principal Who Cracks Down on Stress
The New York Times - New gene therapy brings hope to cancer patients
Sidney Morning Herald - Private equity firm completes $3.7B buyout of eye products maker Bausch & Lomb
International Herald Tribune - Who's In Charge Of Finding Cures?
Forbes - House Passes Revised Children's Health Bill, but Timing Irks GOP
The Washington Post - Charlotte seeks spotlight in medical device arena
Independent Tribune - Seeking Savings, Employers Help Smokers Quit
The New York Times - Judges to rule Friday on stem cell referendum
Associated Press - Controversial DNA Scientist Retires
Associated Press - A Battle Over Venture Capital for Small Businesses
The New York Times - Whistle-Blower Finds a Finger Pointing Back
The New York Times - Garnier taking the painful medicine
Financial Times - Drive toward cheaper biotech drugs advances
Chicago Tribune - Medicare medical chief sees no new ESA-drug evidence
Reuters - House to Vote on New Version of Child Health Bill
The New York Times - Synthetic life 'no terror threat'
BBC - Inquiries at Investor-Owned Nursing Homes
The New York Times - Minnesota Looks for Investment in India
Associated Press - Stem cell lab takes first step
The Star-Ledger - Amgen Wins a Crucial Patent Ruling
The New York Times - Science campaigns for cash
Baltimore Sun - F.D.A. Tests on Devices Scrutinized
The New York Times - Scientist sues over opinion piece
The Scientist - Pig-cell trial patient able to stop insulin
New Zealand Herald - An Active, Purposeful Machine That Comes Out at Night to Play
The New York Times - In New Hampshire, health care sways elderly votes
Reuters - Fraud and Florida's multimillion-dollar wheelchair
Reuters - The Asterisk on Cancer Deaths
The New York Times - Criminal Element
The New York Times - Genetic factor in AIDS progression is higher than thought: study
AFP - Democrats Press Ahead on SCHIP
The Washington Post - Weak Sales Prompt Pfizer to Cancel Diabetes Drug
The New York Times - Ban Complex Drugs for Children, Official Says
The New York Times - As he arrives in Britain, DNA pioneer breaks his silence on racism row
The Independent - Vulnerability to Stress Linked to Brain Molecule
HealthDay News - Google says working to solve health record dilemma
Reuters - Stem cell work under investigation
The Scientist - Democrats Look Ahead as Veto Override Falters
The New York Times - Senate Democrats Drop Plan to Challenge Stem Cell Restrictions
Bloomberg - Global Gene Map Clears New Milestone
HealthDay News - Amgen Defends Its Turf as Competition Looms for Anemia Drug
The New York Times - Amgen, J&J Anemia Drug Limits Backed by U.S. Agency
Bloomberg - Deadly Bacteria Found to Be More Common
The New York Times - Research leaders urge state to keep incentives coming
Palm Beach Post - Device Woes Said Reported Before Recall
Associated Press - Heart Device Recall Poses a Quandary for Patients
The New York Times - Study of 1,000 gay kin seeks genetic clues to homosexuality
Associated Press
Back « ... 11 12 13 14 15 16 17 18 19 20 » Next
- Lung cancer pill may get second chance after tests
Reuters - Too Much Information
The New York Times - Popular Radio Host Has Drug Company Ties
The New York Times - Rapid DNA Test Could Reveal Patient Genome in Minutes Some Day
Bloomberg - Obama’s Pick of Daschle May Test Conflict-of-Interest Pledge
The New York Times - Personal medicine is goal of Eli Lilly & Co.
The Arizona Republic - Health Insurers Offer to Accept All Applicants, on Condition
The New York Times - Amgen, Takeda's Cancer Drug Test Stopped After Deaths
Bloomberg - Fast-food ad ban could cut child obesity: U.S. study
Reuters - Federal Court Upholds Drug Privacy Law
The New York Times